Occlutech Obtains Ce Mark For The New Generation Pfo & Asd Occluders

< BACK TO HEALTH starstarstarstarstar   Community - Health Press Release
12th May 2009, 10:54pm - Views: 419





Community Health Occlutech GmbH 1 image




Occlutech Obtains CE Mark for the new Generation PFO & ASD Occluders


JENA, May 12 /PRNewswire-AsiaNet/ -


    Occlutech, the leading European developer of septum occluders, today announced that it has

obtained CE mark approval for its new generation ASD and PFO occluders, the Figulla Flex.


    The Figulla Flex ASD and PFO occluders encompass a new innovative delivery system, making

the use of a threaded hub unnecessary. The implantation of the occluder is facilitated by the ability

of the delivery system to allow a 45 degree angle before release.


    The Occlutech Figulla Flex will be exhibited and demonstrated at the PCR

vascular intervention meeting in Barcelona from May 19th to May 22nd.


    Occlusion devices are used to treat structural heart disease, including structural heart defects

and abnormalities such as Atrial Septal Defects, (ASD), and Patent Foramen Ovale (PFO, an

undesired channel between the heart's two atria, present in up to 25% of the population), in

minimally invasive, non-surgical procedures. The market for PFO occluders is expected to expand

significantly as the link between PFO and stroke, that is the third most common cause of death, as

well as severe migraine becomes increasingly well documented.

    

    Contact:


    Tor Peters

    info@occlutech.de

    Tel: +49-3641-67-51-29


    Katrin Biedermann

    katrin.biedermann@occlutech.de

    Tel.: +49-3641-67-51-20


    SOURCE: Occlutech GmbH











news articles logo NEWS ARTICLES
Contact News Articles |Remove this article